Treasury Wine Estates (ASX:TWE), the global producer behind premium brands like Penfolds and Wolf Blass, saw its shares tumble to a decade low on Monday after the company scrapped its fiscal 2026 earnings forecast. The wine giant attributed the move to slowing demand in China and ongoing challenges in its U.S. operations.
The Sydney-listed stock plunged as much as 14.2% to A$5.99, marking its lowest point since September 2015. The drop came after Treasury Wine announced it no longer viewed its previous “low to mid double-digit” earnings growth projection for fiscal 2026 as realistic.
According to preliminary figures, sales of the company’s flagship Penfolds brand in China underperformed expectations despite modest improvement in September. Weaker consumer demand persisted through the Mid-Autumn Festival period, a traditionally strong sales window for luxury wines. The disappointing figures highlight the continued volatility in China’s premium wine market following recent economic headwinds.
In the United States, Treasury Americas also struggled due to a distributor transition in California. The company is currently negotiating a settlement with former distributor Republic National Distribution Company, with unresolved issues around inventory treatment potentially weighing further on shipments and revenue in the current fiscal year.
Adding to investor unease, Treasury Wine Estates announced a pause on its A$200 million share buyback program, pending greater visibility on trading conditions and global demand trends.
The setback underscores the mounting pressure facing international wine producers amid shifting global consumption patterns and economic uncertainty. Analysts suggest Treasury Wine may need to recalibrate its growth strategy as it navigates slower recovery in China and operational challenges in the U.S., its two largest export markets.


Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
First Western Ship Transits Strait of Hormuz Since Iran War Began
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Apple Turns 50: From Garage Startup to AI Crossroads
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 



